Clinical Trial

AMEND TS Early Feasibility Study

Recruiting
View on ClinicalTrials.gov →
Summary
Valcare Medical AMEND Trans-Septal System is a mitral valve repair annuloplasty ring implanted in a trans-catheter method intended for correction of mitral regurgitation. It is designed to be used as standalone therapy or in combination with other repair treatments.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-04-22; most recent amendment 2026-01-05.
Status change: Not Yet Recruiting → Recruiting 2026-01-05
Trial Details
NCT Number NCT06951672
Lead Sponsor Valcare Medical Ltd.
Conditions Symptomatic Functional MR 3 or Greater
Enrollment 15 participants
Start Date 2025-09-11
Primary Completion 2026-10 (estimated)
Study Completion 2027-04 (estimated)
Updated on ClinicalTrials.gov 2026-01-07